JP2010516779A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516779A5
JP2010516779A5 JP2009547377A JP2009547377A JP2010516779A5 JP 2010516779 A5 JP2010516779 A5 JP 2010516779A5 JP 2009547377 A JP2009547377 A JP 2009547377A JP 2009547377 A JP2009547377 A JP 2009547377A JP 2010516779 A5 JP2010516779 A5 JP 2010516779A5
Authority
JP
Japan
Prior art keywords
compound according
substituent
compound
con
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009547377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516779A (ja
JP5394933B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/051650 external-priority patent/WO2008091860A1/en
Publication of JP2010516779A publication Critical patent/JP2010516779A/ja
Publication of JP2010516779A5 publication Critical patent/JP2010516779A5/ja
Application granted granted Critical
Publication of JP5394933B2 publication Critical patent/JP5394933B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009547377A 2007-01-22 2008-01-22 眼圧降下剤として有用なチオフェン誘導体 Expired - Fee Related JP5394933B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88601307P 2007-01-22 2007-01-22
US60/886,013 2007-01-22
PCT/US2008/051650 WO2008091860A1 (en) 2007-01-22 2008-01-22 Thiophene derivatives useful as ocular hypotensive agents

Publications (3)

Publication Number Publication Date
JP2010516779A JP2010516779A (ja) 2010-05-20
JP2010516779A5 true JP2010516779A5 (cg-RX-API-DMAC7.html) 2011-03-10
JP5394933B2 JP5394933B2 (ja) 2014-01-22

Family

ID=39420781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009547377A Expired - Fee Related JP5394933B2 (ja) 2007-01-22 2008-01-22 眼圧降下剤として有用なチオフェン誘導体

Country Status (7)

Country Link
US (1) US8039496B2 (cg-RX-API-DMAC7.html)
EP (1) EP2114913B1 (cg-RX-API-DMAC7.html)
JP (1) JP5394933B2 (cg-RX-API-DMAC7.html)
AT (1) ATE511506T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008207991B9 (cg-RX-API-DMAC7.html)
CA (1) CA2675981A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008091860A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5532302B2 (ja) * 2006-07-10 2014-06-25 アラーガン インコーポレイテッド 治療化合物
WO2009132087A1 (en) * 2008-04-24 2009-10-29 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
US7803797B2 (en) * 2008-04-24 2010-09-28 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
JP6569661B2 (ja) * 2014-02-27 2019-09-04 小野薬品工業株式会社 選択的ep2アゴニスト活性を有する化合物
JP6773035B2 (ja) 2015-07-23 2020-10-21 小野薬品工業株式会社 Ep2アゴニスト活性を有する化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6291522B1 (en) * 2000-09-27 2001-09-18 Allergan Sales, Inc. Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
BR0213911A (pt) * 2001-11-05 2004-09-28 Allergan Inc Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2
US7183310B2 (en) * 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
CA2657967A1 (en) * 2006-06-20 2007-12-27 Allergan, Inc. Cyclopentane derivatives as antiglaucoma agents
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
WO2009132087A1 (en) * 2008-04-24 2009-10-29 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
US7803797B2 (en) * 2008-04-24 2010-09-28 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents

Similar Documents

Publication Publication Date Title
JP2009543795A5 (cg-RX-API-DMAC7.html)
JP2010530897A5 (cg-RX-API-DMAC7.html)
JP2009541340A5 (cg-RX-API-DMAC7.html)
JP2011500818A5 (cg-RX-API-DMAC7.html)
JP2011527331A5 (cg-RX-API-DMAC7.html)
JP2011518775A5 (cg-RX-API-DMAC7.html)
JP2013505929A5 (cg-RX-API-DMAC7.html)
JP2010540477A5 (cg-RX-API-DMAC7.html)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2010516779A5 (cg-RX-API-DMAC7.html)
JP2009543792A5 (cg-RX-API-DMAC7.html)
JP2009114217A5 (cg-RX-API-DMAC7.html)
JP2009519903A5 (cg-RX-API-DMAC7.html)
JP2010500976A5 (cg-RX-API-DMAC7.html)
JP2013509487A5 (cg-RX-API-DMAC7.html)
JP2012503016A5 (cg-RX-API-DMAC7.html)
JP2009535426A5 (cg-RX-API-DMAC7.html)
JP2004524340A5 (cg-RX-API-DMAC7.html)
JP2010510232A5 (cg-RX-API-DMAC7.html)
JP2013521301A5 (cg-RX-API-DMAC7.html)
JP2009543794A5 (cg-RX-API-DMAC7.html)
CA2796933A1 (en) 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
JP2009184932A5 (cg-RX-API-DMAC7.html)
EA200800294A1 (ru) Способы нейропротекции
JP2010534246A5 (cg-RX-API-DMAC7.html)